High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer

Tumor infiltrating lymphocytes (TILs) are closely related to the patients’ prognosis. Recently, Microrchidia 2 (MORC2) has been documented as a prognostic and predictive biomarker in triple negative breast cancer (TNBC). To compare whether MORC2 is a better predictor than TILs, as well as clinicopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xiaohong, Liu, Chao, Ding, Zhenluo, Wang, Chen, He, Jing, Wu, Shugui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289757/
https://www.ncbi.nlm.nih.gov/pubmed/37352040
http://dx.doi.org/10.1097/MD.0000000000034164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289757/
https://www.ncbi.nlm.nih.gov/pubmed/37352040
http://dx.doi.org/10.1097/MD.0000000000034164

Ejemplares similares